View by Specialty

Trending

Research files Adobe
September 26, 2024
1 min read
Save

NIH finds neuroscience director engaged in research misconduct

Respiratory Infections News

SPONSORED CONTENT
Save
SPONSORED CONTENT
October 20, 2021
3 min read
Save

White House announces COVID-19 vaccine plan for children aged 5 to 11 years

White House announces COVID-19 vaccine plan for children aged 5 to 11 years

The White House announced a rollout plan to vaccinate children aged 5 to 11 years against COVID-19 should the FDA authorize the use of the Pfizer-BioNTech vaccine in this age group.

SPONSORED CONTENT
October 19, 2021
2 min read
Save

Interferon adds no clinical benefit for hospitalized patients with COVID-19

Interferon adds no clinical benefit for hospitalized patients with COVID-19

Combining the immunomodulator interferon beta-1a with remdesivir did not improve treatment among hospitalized adults with COVID-19 compared with remdesivir alone, data from a clinical trial showed.

Trending

Research files Adobe
September 26, 2024
1 min read
Save

NIH finds neuroscience director engaged in research misconduct

SPONSORED CONTENT
October 18, 2021
2 min read
Save

ACP partners with YouTube to combat COVID-19 misinformation

ACP partners with YouTube to combat COVID-19 misinformation

The ACP announced that it is working with YouTube to develop messages to counteract misinformation about COVID-19, its treatment and vaccines.

SPONSORED CONTENT
October 18, 2021
2 min read
Save

Physicians 'practicing medicine blind' in areas without adequate access to diagnostics

Physicians 'practicing medicine blind' in areas without adequate access to diagnostics

Nearly half of the world’s population, primarily in low- and middle-income countries, has little to no access to essential diagnostic tools for common diseases, according to findings published by The Lancet Commission on Diagnostics.

SPONSORED CONTENT
October 17, 2021
2 min read
Save

Lefamulin a safe, effective alternative to moxifloxacin for unilobar, multilobar pneumonia

Lefamulin a safe, effective alternative to moxifloxacin for unilobar, multilobar pneumonia

In a pooled analysis of the LEAP 1 and LEAP 2 trials, lefamulin was safe and its efficacy was comparable to that of moxifloxacin in patients with unilobar and multilobar community-acquired bacterial pneumonia.

SPONSORED CONTENT
October 17, 2021
1 min read
Save

Rapid assay accurately detects drug-resistant TB

Rapid assay accurately detects drug-resistant TB

A rapid sputum-based assay accurately detected resistance to isoniazid, fluoroquinolones, ethionamide, amikacin, kanamycin and capreomycin in people with tuberculosis symptoms, showing its potential to diagnose drug-resistant TB.

SPONSORED CONTENT
October 15, 2021
1 min read
Save

FDA committee recommends second J&J shot at 2 months

FDA committee recommends second J&J shot at 2 months

An FDA advisory committee on Friday unanimously recommended that anyone who received the Johnson & Johnson COVID-19 vaccine should be able to receive a second dose at least 2 months after receiving their initial shot.

SPONSORED CONTENT
October 14, 2021
1 min read
Save

FDA advisory committee unanimously recommends Moderna booster shot

FDA advisory committee unanimously recommends Moderna booster shot

An FDA advisory committee on Thursday unanimously recommended the authorization of a booster dose of Moderna’s COVID-19 messenger RNA vaccine for certain people, to be given at half the regular dose.

SPONSORED CONTENT
October 14, 2021
4 min read
Save

‘A global wake-up call’: In shadow of COVID-19, TB deaths rise for first time in 15 years

‘A global wake-up call’: In shadow of COVID-19, TB deaths rise for first time in 15 years

Disruptions caused by the COVID-19 pandemic have reversed years of global progress in the fight against tuberculosis, leading to an increase in deaths from TB for the first time in over a decade, according to WHO’s 2021 Global TB report.

SPONSORED CONTENT
October 14, 2021
2 min read
Save

More than half of COVID-19 survivors experience symptoms 6 months after recovery

More than half of COVID-19 survivors experience symptoms 6 months after recovery

More than half of COVID-19 survivors experience symptoms consistent with long COVID up to 6 months after recovery, data from a systematic review published in JAMA Network Open showed.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails